EUVIMEDEUVIMED entdecken
Crossref

Novel N or N modified α-carboline analogues as potential ligands in Alzheimer's disease therapy: Synthesis and neurobiological activity evaluation

Wenjia Dan, Yidan Cao, Yifan Sun, Jiaoyue Zhang, Jinyi Liu, Jixiang Gao, Rui Han, Jiangkun Dai

Bioorganic Chemistry · 2023

DOI: 10.1016/j.bioorg.2023.106378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Wenjia Dan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Weifang Medical University, Shandong, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of new α-carboline analogues modified at N1 or N9 positions by alkyl, benzyl and phenyl were synthesized and characterized as potential ligands for AD therapy. These compounds exhibited multifunctional neurobiological activities including anti-neuroinflammatory, neuroprotective and cholinesterase inhibition. Among them, compound 5d with good drug-like properties and no cytotoxicity, showed potent inhibitory activity against NO production (IC50 = 1.45 μM), which could suppress the expression levels of iNOS and COX-2 in a dose-dependent manner. Further mechanism exploration indicated that compound 5d could regulate the NF-κB signaling pathway by decreasing the phosphorylation of IκB-α and p65. Notably, compound 5d could effectively decrease the LPS-induced aberrations in zebrafish. Compounds 3b, 4f, 5c, 5g, 5m and 6i exhibited potential neuroprotective activity (cell viability > 70 %) in the H2O2-induced PC-12 neuronal death model and rescued the SOD activity. In particular, compounds 3b, 4f, and 5g activated the Nrf2 signaling pathway, and improved the expressions of antioxidant proteins NQO-1 and HO-1, which alleviated the head cell apoptosis in zebrafish. Additionally, compound 6i exhibited potential inhibitory activity against BuChE with IC50 of 0.77 μM. Overall, this work provided some lead compounds based on α-carboline used for AD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsAnimalsZebrafishHydrogen PeroxideCarbolinesCholinesterase InhibitorsAcetylcholinesterase

Stichwörter der Autor:innen

Anti-neuroinflammatoryCholinesterase inhibitionNF-κBNeuroprotectiveNrf2α-Carboline analogues

Substanzen

alpha-carbolineHydrogen PeroxideCarbolinesNeuroprotective AgentsCholinesterase InhibitorsAcetylcholinesterase

Autor:innen und Institutionen

  • School of Life Science and Technology, Weifang Medical University, Shandong, China.
  • Institute of Basic and Transitional Medicine, Xi'an Medical University, Shannxi, China. Electronic address: hruigsyc@163.com.
  • School of Life Science and Technology, Weifang Medical University, Shandong, China. Electronic address: daijkun@wfmc.edu.cn.

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Dan, W., Cao, Y., Sun, Y., Zhang, J., Liu, J., Gao, J., Han, R., & Dai, J. (2023). Novel N or N modified α-carboline analogues as potential ligands in Alzheimer's disease therapy: Synthesis and neurobiological activity evaluation. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106378

Vancouver

Dan W, Cao Y, Sun Y, Zhang J, Liu J, Gao J, et al. Novel N or N modified α-carboline analogues as potential ligands in Alzheimer's disease therapy: Synthesis and neurobiological activity evaluation. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106378

BibTeX
@article{Dan2023,
  author = {Dan, Wenjia and Cao, Yidan and Sun, Yifan and Zhang, Jiaoyue and Liu, Jinyi and Gao, Jixiang and Han, Rui and Dai, Jiangkun},
  title = {Novel N or N modified α-carboline analogues as potential ligands in Alzheimer's disease therapy: Synthesis and neurobiological activity evaluation},
  journal = {Bioorganic Chemistry},
  year = {2023},
  doi = {10.1016/j.bioorg.2023.106378}
}
Kostenlos starten →